-
AMPE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ampio Pharmaceuticals (AMPE)
Company Profile
Quarter (USD) | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.09 mm | 4.09 mm | 4.09 mm | 4.09 mm | 4.09 mm | 4.09 mm |
Cash burn (monthly) | 769.67 k | 713.67 k | 738.33 k | 797.83 k | 769.67 k | 713.67 k |
Cash used (since last report) | 11.01 mm | 10.21 mm | 10.56 mm | 11.41 mm | 11.01 mm | 10.21 mm |
Cash remaining | -6.92 mm | -6.12 mm | -6.47 mm | -7.32 mm | -6.92 mm | -6.12 mm |
Runway (months of cash) | -9.0 | -8.6 | -8.8 | -9.2 | -9.0 | -8.6 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 5 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 2.21 mm |
Total shares | 5.60 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 5.60 mm | $2.21 mm |
Proequities | 0.00 | $0.00 |